Lundbeck's third quarterly report of the year is largely as expected and relatively undramatic, assesses Senior Analyst at Sydbank, who nonetheless highlights the fact that sales growth of key products has accelerated in the period.
Lundbeck also maintains its financial guidance for the full year with expected operating profits of DKK 2-2.3bn (USD 311.1-404.5m), which also includes restructuring costs in the range of 100-200m (USD 15.6-31.1m) pertaining to the shutdown of the company's Indian operations and adjustments in the US-based business.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Zealand Pharma sells shares for over USD 100m
With a 5% discount, the biotech company managed to sell 4,975,000 of its own shares in a direct issuance.
Zealand Pharma CEO: Share sale arms us for partnership negotiations
After a study success with short bowel syndrome treatment candidate, the Danish biotech company raised funding by issuing shares, preparing the company’s CEO, Adam Steensberg, to enter dialogs with a number of potential partners.
Complete company divestment is not part of Zealand Pharma's strategy
After a Nordnet analyst brought up the possibility of the Danish company being an acquisition target for foreign firms, CEO Adam Steensberg has ruled out the notion of a full sale.
Three scientists share chemistry Nobel for cancer improvement technology breakthrough
Danish national Morten Meldal and two colleagues have been awarded the prestigious award for their research into click chemistry, which is used the development of cancer drugs.
Audientes builds on Q2 momentum, maintains guidance
The hearing aid company has sold self-fitting hearing aids for over DKK 2m (USD 266,700) during the third quarter that ended in September.
Drug Safety Associate 
Clinical Project Lead 
Senior CMC Regulatory Manager 
Experienced Medical Device Developer 
Downstream Processing CMC Specialist 
Chief Business Officer 
Head of department RA/QA/PV, Danmark 
Pharmacovigilance & Regulatory Officer 
KLIFO is looking for a Senior QA Specialist GMP for our Glostrup office 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Orifarm Healthcare Product Development PMO Director 
Sales Manager Denmark 
Product specialist